• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服的N-乙酰半胱氨酸未渗透到支气管肺泡灌洗液中。

No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid.

作者信息

Cotgreave I A, Eklund A, Larsson K, Moldéus P W

出版信息

Eur J Respir Dis. 1987 Feb;70(2):73-7.

PMID:3817074
Abstract

Six healthy volunteers underwent bronchoalveolar lavage (BAL) before and after receiving N-acetylcysteine (NAC) 600 mg daily for 2 weeks. Free and total NAC, cysteine and glutathione were determined in the lavage fluid, lavage cells and plasma. No NAC was demonstrated, free or bound in disulfides, in either of the lavage components; furthermore, the cysteine and glutathione content of these components and their respective redox states were unaltered during therapy. Plasma free and total cysteine content was unaltered by administration of the drug, but both free and total plasma glutathione increased significantly. Free NAC could not be detected in plasma following dosing. However, a mean of 0.3 nmol/100 microliters plasma was released from disulfides in plasma following reduction with dithiothreitol. N-acetylcysteine has been proposed to act as a mucolytic by cleavage of disulfide bonds. Our findings do not support this direct mode of action and alternative mechanisms of action must be sought.

摘要

六名健康志愿者在每日服用600毫克N-乙酰半胱氨酸(NAC)两周前后接受了支气管肺泡灌洗(BAL)。对灌洗液、灌洗细胞和血浆中的游离和总NAC、半胱氨酸和谷胱甘肽进行了测定。在任何一种灌洗成分中均未检测到游离或结合在二硫键中的NAC;此外,这些成分中的半胱氨酸和谷胱甘肽含量及其各自的氧化还原状态在治疗期间未发生改变。给药后血浆游离和总半胱氨酸含量未改变,但血浆游离和总谷胱甘肽均显著增加。给药后血浆中未检测到游离NAC。然而,用二硫苏糖醇还原后,血浆中二硫键平均释放出0.3纳摩尔/100微升血浆。有人提出N-乙酰半胱氨酸通过裂解二硫键发挥黏液溶解作用。我们的研究结果不支持这种直接作用方式,必须寻找其他作用机制。

相似文献

1
No penetration of orally administered N-acetylcysteine into bronchoalveolar lavage fluid.口服的N-乙酰半胱氨酸未渗透到支气管肺泡灌洗液中。
Eur J Respir Dis. 1987 Feb;70(2):73-7.
2
Lack of effect of N-acetylcysteine on the release of oxygen radicals from neutrophils and alveolar macrophages.
Eur Respir J. 1991 Jun;4(6):723-9.
3
Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers.口服N-乙酰-L-半胱氨酸的效果:吸烟者的多生物标志物研究
Cancer Epidemiol Biomarkers Prev. 2002 Feb;11(2):167-75.
4
Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine.用N-乙酰半胱氨酸治疗后血浆和支气管肺泡灌洗液中的半胱氨酸和谷胱甘肽浓度。
Thorax. 1991 Jan;46(1):39-42. doi: 10.1136/thx.46.1.39.
5
Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage.放射性标记的N-乙酰-L-半胱氨酸在斯普拉格-道利大鼠体内的分布及其单次和重复灌胃给药后对谷胱甘肽代谢的影响。
Cutan Ocul Toxicol. 2007;26(2):113-34. doi: 10.1080/15569520701212233.
6
Nebulized N-acetyl cysteine protects the pulmonary graft inside the non-heart-beating donor.雾化吸入N-乙酰半胱氨酸可保护非心脏跳动供体的肺移植器官。
J Heart Lung Transplant. 2005 Sep;24(9):1369-77. doi: 10.1016/j.healun.2004.10.013.
7
Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats.口服N-乙酰半胱氨酸可减轻吸烟诱导的大鼠慢性阻塞性肺疾病(COPD)中的肺气肿和肺泡间隔细胞凋亡。
Respirology. 2009 Apr;14(3):354-9. doi: 10.1111/j.1440-1843.2009.01511.x.
8
N-acetyl cysteine attenuates acute lung injury in the rat.N-乙酰半胱氨酸减轻大鼠急性肺损伤。
Shock. 1997 Dec;8(6):432-8.
9
Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variables.
Eur Respir J. 1988 Oct;1(9):832-8.
10
Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury.N-乙酰半胱氨酸在高氧性肺损伤中对锰超氧化物歧化酶的过表达作用
Respir Med. 2007 Apr;101(4):800-7. doi: 10.1016/j.rmed.2006.07.017. Epub 2006 Sep 28.

引用本文的文献

1
Molecular Hydrogen Ameliorates Anti-Desmoglein 1 Antibody-Induced Pemphigus-Associated Interstitial Lung Disease by Inhibiting Oxidative Stress.分子氢通过抑制氧化应激改善抗桥粒芯糖蛋白1抗体诱导的天疱疮相关性间质性肺疾病。
Int J Mol Sci. 2025 Apr 28;26(9):4203. doi: 10.3390/ijms26094203.
2
Physiology and pathophysiology of mucus and mucolytic use in critically ill patients.危重症患者黏液的生理学与病理生理学及黏液溶解剂的应用
Crit Care. 2025 Feb 7;29(1):68. doi: 10.1186/s13054-025-05286-x.
3
Efficacy and Safety of Hydrogen Therapy in Patients with Early-Stage Interstitial Lung Disease: A Single-Center, Randomized, Parallel-Group Controlled Trial.
氢气疗法对早期间质性肺疾病患者的疗效与安全性:一项单中心、随机、平行组对照试验
Ther Clin Risk Manag. 2023 Dec 11;19:1051-1061. doi: 10.2147/TCRM.S438044. eCollection 2023.
4
Current and Future Treatments in Primary Ciliary Dyskinesia.原发性纤毛运动障碍的当前和未来治疗方法。
Int J Mol Sci. 2021 Sep 11;22(18):9834. doi: 10.3390/ijms22189834.
5
Bottom-up analysis of emergent properties of N-acetylcysteine as an adjuvant therapy for COVID-19.对N-乙酰半胱氨酸作为COVID-19辅助治疗药物的涌现特性进行自下而上的分析。
World J Virol. 2021 Mar 25;10(2):34-52. doi: 10.5501/wjv.v10.i2.34.
6
Considerations for and Mechanisms of Adjunct Therapy in COPD.慢性阻塞性肺疾病辅助治疗的考量因素及机制
J Clin Med. 2021 Mar 16;10(6):1225. doi: 10.3390/jcm10061225.
7
Scientific Papers and Patents on Substances with Unproven Effects. Part 2.关于效果未经证实物质的科学论文与专利。第2部分。
Recent Pat Drug Deliv Formul. 2019;13(3):160-173. doi: 10.2174/1872211313666190819124752.
8
Nebulised -Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature.雾化吸入乙酰半胱氨酸治疗变应性支气管肺曲霉病中难治性支气管阻塞:病例系列及文献综述
J Fungi (Basel). 2018 Oct 15;4(4):117. doi: 10.3390/jof4040117.
9
Airway Mucus and Asthma: The Role of MUC5AC and MUC5B.气道黏液与哮喘:MUC5AC和MUC5B的作用
J Clin Med. 2017 Nov 29;6(12):112. doi: 10.3390/jcm6120112.
10
Oxidation increases mucin polymer cross-links to stiffen airway mucus gels.氧化作用会增加黏蛋白聚合物交联,从而使气道黏液凝胶变硬。
Sci Transl Med. 2015 Feb 25;7(276):276ra27. doi: 10.1126/scitranslmed.3010525.